联合应用头孢曲松钠、奥曲肽与奥美拉唑治疗肝硬化上消化道出血的临床效果

邵立明

（陕西省汉中市第二人民医院，陕西 汉中，723000）

浏览次数：141次 下载次数：320次

摘要：

目的 观察肝硬化合并上消化道出血患者采用头孢曲松钠、奥曲肽、奥美拉唑联合治疗的临床效果。方法 选取我院收治的90例肝硬化合并上消化道出血患者为研究对象，随机分为对照组和观察组，各45例。对照组患者采用奥曲肽加奥美拉唑治疗，观察组患者采用头孢曲松钠加奥曲肽加奥美拉唑治疗，比较两组患者的治疗效果。结果 治疗后，观察组患者总有效率为93.3%，显著高于对照组的64.4%（P<0.05）；观察组患者的平均止血时间、住院时间、48h再出血率明显优于对照组（P<0.05）；两组患者不良反应发生率比较，差异无统计学意义（P>0.05）。结论 应用头孢曲松钠加奥曲肽加奥美拉唑治疗肝硬化合并上消化道出血，临床效果显著，值得临床推广应用。

关键词：头孢曲松钠；奥曲肽；奥美拉唑；肝硬化；上消化道出血

中图分类号：R575.2文献标志码：A文章编号：2096-1413(2017)12-0031-02

Clinical effect of combined use of ceftriaxone sodium, octreotide and omeprazole in the treatment of liver cirrhosis upper gastrointestinal bleeding
SHAO Li-ming
（the Second People s Hospital of Hanzhong City, Hanzhong 723000, China）

ABSTRACT: Objective To observe the clinical effect of the combined use of ceftriaxone sodium, octreotide and omeprazole in the treatment of liver cirrhosis upper gastrointestinal bleeding. Methods Ninety cases of patients with liver cirrhosis upper gastrointestinal bleeding were selected and randomly divided into control group and observation group, with 45 cases in each group. The control group used the octreotide plus omeprazole treatment, while the observation group accepted combined use of ceftriaxone sodium, octreotide and omeprazole. The clinical effects of the two groups were compared. Results After treatment, the total effective rate of the observation group was 93.3% , which was higher than 64.4% of the control group (P<0.05). The average bleeding time, length of hospital stay and bleeding rate after 48 h of the observation group were better than those of the control group (P<0.05). There was no significant difference on the rate of adverse reactions between two groups (P>0.05). Conclusion Combined use of ceftriaxone sodium, octreotide and omeprazole has significant clinical effect in the treatment of liver cirrhosis upper gastrointestinal bleeding, which is worthy of clinical application and popularization.
KEYWORDS: ceftriaxone sodium; octreotide; omeprazole; liver cirrhosis; upper gastrointestinal bleeding

参考文献：
[1] 陈敏锋,邓启明,林颖华.奥曲肽联合奥美拉挫治疗肝硬化上消化道出血疗效的Meta 分析[J].中国当代医药,2013,20(14):168-169.
[2] 朱辉,刘玮,韩香.奥曲肽治疗上消化道出血研究进展[J].武警医学院学报,2011,20(1):76-78.

[3] 李浩,徐红,李硕.奥曲肽联合奥美拉唑治疗肝硬化并发上消化道出血的疗效观察[J].齐齐哈尔医学院学报,2012,33(15):2061-2062.
[4] 陈敏锋,邓启明,林颖华.奥曲肽联合奥美拉唑治疗肝硬化上消化道出血疗效的Meta分析[J].中国当代医药,2013,20(14):167-169.
[5] 胡又非.奥曲肽联合奥美拉唑治疗肝硬化合并上消化道出血疗效分析[J].医学理论与实践,2013,26(12):1608-1609.
[6] 段连强,杨冬梅.奥曲肽联合奥美拉唑治疗肝硬化并上消化道出血的临床研究[J].临床医学工程,2012,19(1):55-56.
[7] 张健,吴友伟,史丽萍.奥曲肽联合奥美拉唑治疗肝硬化并上消化道出血的疗效评价[J].实用临床医药杂志,2013,17(19):97-99.